Content about Anti-diabetic drug

July 23, 2012

Study: Long-term use of linagliptin among Type 2 diabetics is effective

Extended use of the oral DPP-4 inhibitor linagliptin to lower blood-glucose levels by Type 2 diabetes patients is effective, according to a new study.

December 7, 2011

Data from Qnexa study presented at World Diabetes Congress

Obese diabetes patients could experience weight loss when taking Vivus' anti-obesity drug, according to an oral presentation at the International Diabetes Federation's World Diabetes Congress in Dubai.

October 14, 2011

DPP-IV inhibitors, GLP-1 analogues to see strongest growth among Type 2 diabetes drugs through 2020, study finds

Two classes of drugs for treating Type 2 diabetes will experience the biggest growth in market share of all classes of drugs for the condition, according to a new study by Decision Resources.

September 8, 2011

Boehringer Ingelheim, Eli Lilly present data from studies of diabetes drugs

Boehringer Ingelheim and Eli Lilly will present data from their diabetes portfolio at the 47th Annual Meeting of the European Association for the Study of Diabetes in Lisbon, Portugal.

August 11, 2011

Study: Medicare Part D diabetes patients show better adherence with mail order

Medicare Part D beneficiaries showed better adherence to their oral diabetes drugs when receiving them by mail order, according to a new study.

June 17, 2011

Liraglutide may prompt optimal blood-glucose levels in Type 1 diabetics

A popular Type 2 diabetes treatment may help Type 1 diabetics achieve control of their blood-glucose levels, according to a small, observational study conducted at the University of Buffalo.

February 14, 2011

Avandia's labeling information revised

GlaxoSmithKline has changed prescribing information on the labeling for one of its Type 2 diabetes drugs to reflect new restrictions on the drug’s use, the drug maker said.

January 13, 2011

Novo Nordisk develops Cornerstones4Care as diabetes resource

Danish drug maker Novo Nordisk has created an online resource for diabetes patients that educates them about Novo Nordisk drugs and devices, recipes and nutritional values, and allows them to connect with other patients.

August 4, 2010

Victoza improves blood-sugar levels in African-Americans, study finds

African-Americans with Type 2 diabetes taking a Novo Nordisk drug showed improvements in blood sugar,...

July 18, 2010

As diabetes rates grow, R&D pipelines flow

Research and development pipelines are flowing with a record number of drugs for treating diabetes...

June 9, 2010

MannKind: Afrezza works just as effectively as competing diabetes drugs in trial

An investigational insulin made by MannKind works at least as well in patients with Type...